Literature DB >> 13231011

Vitamin K1 in the control of phenylindanedione-induced anticoagulant therapy.

A ENGLISH, S R TOWNSEND, D G CAMERON.   

Abstract

Entities:  

Keywords:  PHENINDIONE/effects; PROTHROMBIN/deficiency; VITAMIN K/therapeutic use

Mesh：

Substances：

Year:  1955        PMID： 13231011      PMCID： PMC1825584     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  8 in total

1.  The choice of an anticoagulant.

Authors:  K W BROWN; R L MACMILLAN
Journal:  Am J Med Sci       Date:  1954-05       Impact factor: 2.378

2.  Studies on the anticoagulant phenylindanedione. I. The effect of emulsified vitamin K1 on phenylindanedione-induced hypoprothrombinemia.

Authors:  C G GUTTAS; W C MOLONEY; H S SISE
Journal:  Blood       Date:  1953-03       Impact factor: 22.113

3.  Effect in man of a new indandione anticoagulant.

Authors:  J B FIELD; M S GOLDFARB; A G WARE; G C GRIFFITH
Journal:  Proc Soc Exp Biol Med       Date:  1952-12

4.  Antagonism of anticoagulants dicoumarol, tromexan, and phenylindandione by vitamin K.

Authors:  M TOOHEY
Journal:  Br Med J       Date:  1952-09-27

5.  Bishydroxycoumarin, ethyl biscoumacetate, and 4-hydroxycoumarin anticoagulant No. 63; comparative effects.

Authors:  N W BARKER; H H HANSON; F D MANN
Journal:  J Am Med Assoc       Date:  1952-01-26

6.  The response of dicumarol-induced hypoprothrombinemia to vitamin K.

Authors:  A REHBEIN; A JARETZKI; D V HABIF
Journal:  Ann Surg       Date:  1952-04       Impact factor: 12.969

7.  A new prothrombopenic drug, phenylindanedione.

Authors:  L B JAQUES; E GORDON E LEPP
Journal:  Can Med Assoc J       Date:  1950-05       Impact factor: 8.262

8.  Preliminary report on the clinical use of a new anticoagulant, phenylindandione.

Authors:  A U BLAUSTEIN; J J CROCE; M ALBERIAN; N RICHEY
Journal:  Circulation       Date:  1950-05       Impact factor: 29.690
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.